Solidaginis herba
Synonym(s)
DefinitionThis section has been translated automatically.
Solidagnis herba, dried above-ground parts de goldenrod is used for the treatment of inflammatory diseases of the urinary tract and preventive treatment of urinary stones and kidney gravel.
Quality is specified in the European Pharmacopoeia (Ph. Eur.).
HMPC monograph: Traditional-use: increase urine excretion.
ESCOP monograph: flushing of the urinary tract, for inflammation, kidney gravel, additional therapy for bacterial urinary tract infections.
Commission E-monograph: flushing in inflammatory diseases of the urinary tract, urinary stones, kidney gravel, also preventive in tendency to urinary stones and kidney gravel.
Empirical medicine: irritable bladder, adjuvant in rheumatic complaints.
IngredientsThis section has been translated automatically.
Solidaginis herba contains 1 to 4 % flavonoids, saponins, phenylglycosides, tanning agents, essential oil with about 90 mono- and sesquiterpenes, depending on the type of plant.
Important for the effectiveness are 3,5-dicaffeoyl-quinic acid, neochlorogenic acid, chlorogenic acid, leicarposide and virgaureoside.
EffectsThis section has been translated automatically.
Goldenrod has a weak spasmolytic, diuretic and anti-inflammatory effect. It also has antibacterial, antioxidant effects.
Field of application/useThis section has been translated automatically.
Solidagnis herba is used in flushing therapies for inflammatory diseases of the urinary tract and for the prevention of renal gravel and urinary stones. Further indications are rheumatic complaints and irritable bladder.
DosageThis section has been translated automatically.
The usual daily dose is between 6 and 12 g. The drug is used for infusions and other galenic preparations for ingestion.
Undesirable effectsThis section has been translated automatically.
Rarely allergic reactions or gastrointestinal complaints
ContraindicationThis section has been translated automatically.
In case of edema due to impaired cardiac or renal activity, it should not be taken. Children under 12 years, as well as pregnancy and lactation due to lack of data.
InteractionsThis section has been translated automatically.
There are no known interactions with other ingredients. do not use concurrently with synthetic diuretics.
Recipe(s)This section has been translated automatically.
The fixed combination bearberry leaves+goldrod+orthosiphon leaves consists of:
- Uvae ursi folium (bearberry leaves)
- Solidaginis herba (goldenrod)
- Orthosiphonis folium (Orthosiphon leaves)
has an anti-inflammatory, slightly antispasmodic, bacteriostatic effect in an alkaline environment, promotes urinary excretion and is used as a support in inflammatory diseases of the urinary tract.
The fixed combination of birch leaves+goldrod+orthosiphon leaves consists of
- Betulae folium (birch leaves)
- Solidaginis herba (goldenrod)
- Orthosiphonis folium (Orthosiphon leaves)
has an anti-inflammatory, slightly antispasmodic effect, promotes urinary excretion and is used as a preventive measure against renal gravel and as part of a flushing therapy for inflammatory diseases of the urinary tract.
Trade namesThis section has been translated automatically.
A commercially available fixed combination of: Genuine goldenrod+Hauhechel root+Orthosiphon leaves is used in cases of known kidney stone disease. Furthermore with Z.n. lithotripsy:
- Solidaginis herba (goldenrod)
- Hauhechel Root
- Orthosiphon sheets
- = Aqualibra® (2-2-2 tbl./day)
Note(s)This section has been translated automatically.
During a flushing therapy, care must be taken to ensure a sufficient fluid intake of at least 2 l/day.
The stem content of the drug should be less than 20 %, otherwise the content of active ingredients is too low. The highest content of active ingredients is in the leaves and flowers of the plant.
LiteratureThis section has been translated automatically.
- Schilcher H (2016) in, Leitfaden Phytotherapie, Urban & Fischer Verlag München, p. 144 f.
- https://arzneipflanzenlexikon.info/goldrude.php
- https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-solidago-virgaurea-l-herba_en.pdf
- Wenigmann M. (2017) Phytotherapy medicinal drugs, phytopharmaceuticals, application. Urban & Fischer, pp. 116-117